MAPT and Atrophy: Through careful investigations, a few mouse models expressing human tau with P301L/S mutation provided pathological criteria such as intracellular filamentous tau inclusions, biochemically confirmed hyperphosphorylated tau, neuronal loss, and brain atrophy.